The report offers an important new lens to inform global and national health policy on the biology of aging in the context of the 21st-century megatrend of aging. It calls for more attention to, further research into and increased leadership for action on the relationship between health innovation and the impact of chronic inflammation and…

Released amid increasing recognition of the threat posed by the “silent pandemic” of antimicrobial resistance at the highest levels of government, most recently at the G7 Summit in Cornwall, the report identifies a broad failure to match public promises with the concrete actions needed to avert the growing crisis. The index assessed the 11 largest…

The playbook offers step-by-step guidance to replicate the successful vaccine confidence initiative led by GCOA with the Age-friendly NYC Commission, in early 2021. It is based on a series of community-focused webinars that convened health and medical experts as well as community leaders from across New York City to address questions and concerns from the community…

This report summarizes key takeaways from our October 2020 virtual roundtable on health innovation and economic growth in Japan. The report highlights the importance of health innovation in Japan and in ageing societies around the world. GCOA and the Health and Global Policy Institute (HGPI) co-organized the roundtable, which was sponsored by Pfizer Japan. The roundtable was…

This report summarizes the key takeaways from an October 2020 virtual roundtable on antimicrobial resistance (AMR) and explores the multifaceted risks posed by AMR in aging societies globally, and Japan in particular. The roundtable was co-organized by GCOA and the Health and Global Policy Institute (HGPI) and sponsored by Pfizer Japan. Click here to read the full press…